We are pleased to announce that our manuscript, "Aspirin and Cardiovascular Risk in Individuals with Elevated Lipoprotein(a): MESA," has been published online with the Journal of the American Heart Association!
Why this research matters: Despite existing therapies, managing cardiovascular disease (CVD) risk in individuals with elevated lipoprotein(a) remains a challenge, especially for primary prevention. This research delves into the potential of aspirin as a tool to address this gap.
A huge thanks to our incredible team of authors: Harpreet S. Bhatia, Patrick Trainor, Samantha Carlisle, Michael Y. Tsai, Michael H. Criqui, Andrew DeFilippis, and Sotirios (Sam) Tsimikas. Their dedication and expertise were instrumental in bringing this study to fruition.
Read the full paper: https://lnkd.in/dTnQ2WYy